Federal Circuit Panel Holds Hatch-Waxman Venue Under the Second Prong of ยง 1400(b) is Based on Actions Related to ANDA Submission
Fish & Richardson Trademark & Copyright Thoughts
NOVEMBER 13, 2020
Valeant Pharmaceuticals North America LLC v. Mylan Pharmaceuticals Inc. 7] If a branded company initiates an infringement action against a generic company within 45 days of receiving notice of ANDA submission, this triggers a 30-month stay during which FDA cannot issue a final approval for the ANDA. [8]
Let's personalize your content